REG - GSK PLC - Director/PDMR Shareholding

RNS Number : 4937M GSK PLC 22 December 2025 GSK plc (the 'Company')Transaction notification1.Details of PDMR/person closely associated with them ('PCA')a)NameWendy Beckerb)Position/statusIndependent Non-Executive Directorc)Initial notification/amendmentInitial notification2.Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitora)NameGSK plcb)LEI5493000HZTVUYLO1D7933.Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducteda)Description of the financial instrumentOrdinary shares of 31 ¼ pence each ('Ordinary Shares')ISIN: GB00BN7SWP63b)Nature of the transactionPurchase of 441 Ordinary Sharesc)Price(s) and volume(s)Price(s)Volume(s)£18.0909441d)Aggregated informationN/A (single transaction)Aggregated volume Pricee)Date of the transaction2025-12-19f)Place of the transactionLondon Stock Exchange (XLON)1.Details of PDMR/person closely associated with them ('PCA')a)NameElizabeth (Liz) McKee Andersonb)Position/statusIndependent Non-Executive Directorc)Initial notification/amendmentInitial notification2.Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitora)NameGSK plcb)LEI5493000HZTVUYLO1D7933.Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducteda)Description of the financial instrumentAmerican Depositary Shares ('ADSs')ISIN: US37733W2044b)Nature of the transactionPurchase of 201 ADSsc)Price(s) and volume(s)Price(s)Volume(s)$48.5550201d)Aggregated informationN/A (single transaction)Aggregated volume Pricee)Date of the transaction2025-12-19f)Place of the transactionNew York Stock Exchange (XNYS)1.Details of PDMR/person closely associated with them ('PCA')a)NameCharles Bancroftb)Position/statusSenior Independent Non-Executive Directorc)Initial notification/amendmentInitial notification2.Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitora)NameGSK plcb)LEI5493000HZTVUYLO1D7933.Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducteda)Description of the financial instrumentAmerican Depositary Shares ('ADSs')ISIN: US37733W2044b)Nature of the transactionPurchase of 1,577 ADSsc)Price(s) and volume(s)Price(s)Volume(s)$48.55501,577d)Aggregated informationN/A (single transaction)Aggregated volume Pricee)Date of the transaction2025-12-19f)Place of the transactionNew York Stock Exchange (XNYS)1.Details of PDMR/person closely associated with them ('PCA')a)NameDr Anne Bealb)Position/statusIndependent Non-Executive Directorc)Initial notification/amendmentInitial notification2.Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitora)NameGSK plcb)LEI5493000HZTVUYLO1D7933.Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducteda)Description of the financial instrumentAmerican Depositary Shares ('ADSs')ISIN: US37733W2044b)Nature of the transactionPurchase of 201 ADSsc)Price(s) and volume(s)Price(s)Volume(s)$48.5550201d)Aggregated informationN/A (single transaction)Aggregated volume Pricee)Date of the transaction2025-12-19f)Place of the transactionNew York Stock Exchange (XNYS)1.Details of PDMR/person closely associated with them ('PCA')a)NameDr Hal Dietzb)Position/statusIndependent Non-Executive Directorc)Initial notification/amendmentInitial notification2.Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitora)NameGSK plcb)LEI5493000HZTVUYLO1D7933.Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducteda)Description of the financial instrumentAmerican Depositary Shares ('ADSs')ISIN: US37733W2044b)Nature of the transactionPurchase of 201 ADSsc)Price(s) and volume(s)Price(s)Volume(s)$48.5550201d)Aggregated informationN/A (single transaction)Aggregated volume Pricee)Date of the transaction2025-12-19f)Place of the transactionNew York Stock Exchange (XNYS)1.Details of PDMR/person closely associated with them ('PCA')a)NameDr Jeannie Leeb)Position/statusIndependent Non-Executive Directorc)Initial notification/amendmentInitial notification2.Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitora)NameGSK plcb)LEI5493000HZTVUYLO1D7933.Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducteda)Description of the financial instrumentAmerican Depositary Shares ('ADSs')ISIN: US37733W2044b)Nature of the transactionPurchase of 202 ADSsc)Price(s) and volume(s)Price(s)Volume(s)$48.5550202d)Aggregated informationN/A (single transaction)Aggregated volume Pricee)Date of the transaction2025-12-19f)Place of the transactionNew York Stock Exchange (XNYS)1.Details of PDMR/person closely associated with them ('PCA')a)NameDr Vishal Sikkab)Position/statusIndependent Non-Executive Directorc)Initial notification/amendmentInitial notification2.Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitora)NameGSK plcb)LEI5493000HZTVUYLO1D7933.Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducteda)Description of the financial instrumentAmerican Depositary Shares ('ADSs')ISIN: US37733W2044b)Nature of the transactionPurchase of 730 ADSsc)Price(s) and volume(s)Price(s)Volume(s)$48.5550730d)Aggregated informationN/A (single transaction)Aggregated volume Pricee)Date of the transaction2025-12-19f)Place of the transactionNew York Stock Exchange (XNYS)1.Details of PDMR/person closely associated with them ('PCA')a)NameLady Susan Symondsb)Position/statusPCA of Sir Jonathan Symonds (Non-Executive Chair)c)Initial notification/amendmentInitial notification2.Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitora)NameGSK plcb)LEI5493000HZTVUYLO1D7933.Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducteda)Description of the financial instrumentOrdinary shares of 31 ¼ pence each ('Ordinary Shares')ISIN: GB00BN7SWP63b)Nature of the transactionPurchase of 1,650 Ordinary Sharesc)Price(s) and volume(s)Price(s)Volume(s)£18.10461,650d)Aggregated informationN/A (single transaction)Aggregated volume Pricee)Date of the transaction2025-12-22f)Place of the transactionLondon Stock Exchange (XLON)About GSKGSK is a global biopharma company with a purpose to unite science, technology, and talent to get ahead of disease together. Find out more at www.gsk.com.Registered in England & Wales:No. 3888792Registered Office:79 New Oxford StreetLondonWC1A 1DGThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END DSHFEDFFEEISEEE